Trials / Completed
CompletedNCT01684800
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial Investigating the Efficacy and Safety of Two Different Dose Levels of Desmopressin for the Treatment of Nocturia in Adult Women
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 178 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate the efficacy and safety of two different dose levels of desmopressin orally disintegrating tablets against placebo for the treatment of nocturia in adult women during 12 weeks treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A. Desmopressin 10 microgram | 1 orally disintegrating tablet every night during study period |
| DRUG | B: Desmopressin 25 microgram | 1 orally disintegrating tablet every night during study period |
| DRUG | C: Placebo | 1 orally disintegrating tablet every night during study period |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-09-13
- Last updated
- 2013-08-23
Locations
36 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01684800. Inclusion in this directory is not an endorsement.